ArticleUrology2014
Assessing the burden of complications after surgery for clinically localized kidney cancer by age and comorbidity status.
Article in Urology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.
- The role of comorbidity assessment in guiding treatment decision-making for women with early breast cancer: a systematic literature review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020Pooled it
- Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis.European radiology · 2019Pooled it
- External validation of the preoperative risk evaluation for partial nephrectomy (PREP) score.BJUI compass · 2026Article
- Combined Robot-Assisted Radical Cystectomy and Robot-Assisted Nephroureterectomy for Synchronous High-Risk Upper Urinary Tract and Bladder Cancer: A Single-Center Retrospective Study and Review of the Literature.Journal of clinical medicine · 2026Article
- Outcomes After Initial Noninterventional Management of Clinical Stage cT1b Renal Masses.European urology open science · 2026Article
- Open versus mini-invasive partial and radical nephrectomy complications: results from the French national health database.BMC urology · 2024Article
- Perinephric Toxic Fat: Impact on Surgical Complexity, Perioperative Outcome, and Surgical Approach in Partial Nephrectomy.Urologia internationalis · 2023Article
- Efficacy and safety of surgery in renal carcinoma patients 75 years and older: a retrospective analysis.BMC urology · 2022Article
- The Prognostic Value of Eight Comorbidity Indices in Older Patients with Cancer: The ELCAPA Cohort Study.Cancers · 2022Article
- [Presurgical assessments].Der Urologe. Ausg. A · 2019Review
- Treatment approaches to small renal masses in patients of advanced age (≥75 years).Turkish journal of urology · 2018Review
- Trends in Aging-Related Services During Nephrectomy: Implications for Surgery in an Aging Population.Journal of the American Geriatrics Society · 2017Observational
- Active surveillance for incidental renal mass in the octogenarian.World journal of urology · 2017Article
- Patient Function and the Value of Surgical Care for Kidney Cancer.The Journal of urology · 2017Article
- Patient function, long-term survival, and use of surgery in patients with kidney cancer.Cancer · 2016Article
- A Critical Analysis of Perioperative Outcomes in Morbidly Obese Patients Following Renal Mass Surgery.Urology · 2016Article
- Extreme obesity does not predict poor cancer outcomes after surgery for renal cell cancer.BJU international · 2016Article
- Renal Cancer in the Elderly.Current urology reports · 2016Review
- Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.World journal of urology · 2015Article
- Evaluation and Management of the Geriatric Urologic Oncology Patient.Current geriatrics reports · 2015Article
Corrections and comments
- Commented on by
Authors and funding
11 authors at 2 institutions in 1 country.
Funding
Abstract
objectiveTo examine the association between high-risk patient status (age >75 years or Charlson comorbidity index count >2) and postoperative complications in patients undergoing surgical management for clinically localized renal tumors. MATERIALS AND
methodsPatients undergoing radical nephrectomy (RN) or partial nephrectomy (PN) (2005-2012) for localized renal cell carcinoma were analyzed. Multivariate logistic regressions were used to test the association between high-risk status and postoperative complications adjusting for patient, tumor, and operative characteristics.
resultsOf 1092 patients undergoing PN (71.9%) or RN (28.1%) for clinically localized renal tumors, 255 (23.4%) were classified as high risk, and 175 patients (16%) developed at least 1 complication (mean 1.6 ± 1.0). Of note, 22.4% and 14.1% of high- and low-risk patients developed a complication, respectively (P = .002). Comparing high- and low-risk patients, significant differences in Clavien I-II (20.4% vs 11.1%; P <.001) and medical (16.1% vs 8.1%, P <.001) complications were observed, whereas no differences were seen in Clavien III-V or surgical complications. No differences in complications were observed comparing patients treated with RN and PN, albeit high-risk patients were more likely to undergo RN (35.3% vs 25.9%, P = .04). After adjustment, the odds of incurring any complication were 1.9 times higher in high- compared with low-risk patients (odds ratio 1.9 [confidence interval 1.3-2.8]).
conclusionRegardless of surgical type, patients deemed high risk by age and comorbidity criteria were more likely to incur a postoperative complication after renal mass resection. Improved understanding of surgical risks in the elderly and infirmed will help better inform patients deciding between active surveillance and resection of renal tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.